Myovant Sciences Ltd. Business Finance Contracts & Agreements
17 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Loan Agreements (2)
- Purchase Agreements (4)
- Stock Agreements (3)
- Underwriting Agreements (3)
- Warrant Agreements (3)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under 2020 Inducement Plan (Non-U.S. Form) (Filed With SEC on May 11, 2021)
- Form of Restricted Stock Unit Grant Notice and (Filed With SEC on November 12, 2020)
- Investor Rights Agreement, dated as of December 27, 2019, by and among the Registrant, Sumitovant Biopharma Ltd. and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 10, 2020)
- Loan Agreement, dated as of December 27, 2019, by and among Sumitomo Dainippon Pharma Co., Ltd., as the Lender, the Registrant, as the Parent, and Myovant Sciences GmbH, as the... (Filed With SEC on February 10, 2020)
- Underwriting Agreement, by and between Myovant Sciences Ltd. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC, and Evercore Group L.L.C., as... (Filed With SEC on May 31, 2019)
- Restricted Stock Award Agreement, dated May 31, 2017, by and between Myovant Sciences Ltd. and Lynn Seely (Filed With SEC on May 24, 2019)
- Second Waiver and Amendment to the Securities Purchase Agreement, dated as of March 30, 2018, , dated October 16, 2017, by and among the Registrant, Myovant Holdings Limited,... (Filed With SEC on August 7, 2018)
- Waiver and Amendment to the Securities Purchase Agreement, dated as of March 28, 2018, by and among the Registrant, Myovant Holdings Limited, Myovant Sciences GmbH, Myovant... (Filed With SEC on August 7, 2018)
- Underwriting Agreement, by and between Myovant Sciences Ltd. and J.P. Morgan Securities LLC, Goldman Sachs& Co. LLC and Barclays Capital Inc., as representatives of the... (Filed With SEC on July 13, 2018)
- Warrant Agreement, dated March 26, 2018, issued to Hercules Capital, Inc (Filed With SEC on March 30, 2018)
- Equity Purchase Agreement, dated October 16, 2017, by and among the Registrant and NovaQuest Pharma Opportunities Fund IV, L.P. and NovaQuest Pharma Opportunities Fund IV... (Filed With SEC on February 13, 2018)
- Securities Purchase Agreement, dated October 16, 2017, by and among the Registrant, Myovant Holdings Limited, Myovant Sciences GmbH, Myovant Sciences Ireland Limited, and Myovant... (Filed With SEC on February 13, 2018)
- Loan and Security Agreement, dated October 16, 2017, by and among the Registrant, Myovant Holdings Limited, Myovant Sciences GmbH, Myovant Sciences Ireland Limited, and Myovant... (Filed With SEC on February 13, 2018)
- Warrant Agreement, dated October 16, 2017, issued to Hercules Capital, Inc (Filed With SEC on October 16, 2017)
- Myovant Sciences Ltd. [] Shares 1 Common Shares ($0.00001 parvalue) Underwriting Agreement (Filed With SEC on October 17, 2016)
- ROIVANT ENDOCRINOLOGY LTD. WARRANT TO PURCHASE SHARES (Filed With SEC on September 30, 2016)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on September 30, 2016)
